🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06964724
Active, not recruiting Observational

NeVa Retrospective Comparative SR Study

NCT06964724 · tracked via the Priya Life Science Turkey tracker
Sponsor
Phase
Observational
Started
2025-06-15
Last updated
2026-03-31

Condition(s) studied

Stroke Acute

Investigational drug(s) / intervention(s)

Mechanical thrombectomy

Mechanical thrombectomy: Mechanical thrombectomy with stent retriever

Study summary

To compare safety and effectiveness of NeVa Stent Retriever (SR) to Control SR in the treatment of stroke caused by large vessel occlusion. The main questions it aims to answer are:

How do recanalization rates for NeVa SR compare with those of the Control SR? How does NeVa SR safety compare with Control SR safety?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Treatment during the enrollment period * Age ≥18 * Baseline modified Thrombolysis in Cerebral Infarction (mTICI) score ≤ 1 * Pre-stroke modified Rankin score (mRS) of 0 or 1 * Internal Carotid Artery (ICA), Middle Cerebral Artery (first segment M1/ second segment M2), basilar artery or vertebral artery occlusion * National Institutes of Health Stroke Scale (NIHSS) score ≥ 8 and ≤ 25 * Thrombectomy procedure initiated within 8h of Time Last Known Well (TLKW) * Intravenous Tissue Plasminogen Activator (IV-tPA) failed, given within 3h of TLKW, or ineligibility for thrombolytic drug Exclusion Criteria: * First line contact aspiration alone or non-study device as first-line device

Primary outcome measure(s)

Trial sites (5)

FacilityCityRegionStatus
Hospital Espanol de Mendoza Mendoza Argentina
CHU LIege Liège Belgium
UK Munster Münster Germany
Republican Vilnius University Hospital Vilnius Lithuania
İstanbul Aydrn Üniversitesi Istanbul Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06964724 on ClinicalTrials.gov ↗ ← All trials in Turkey